Pharma Journalist - Page 113 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

C4XD signs exclusive global licence worth up to $402 million with AstraZeneca for the development and commercialisation of NRF2 Activator programme

Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline

Exploring the Implementation of Complex In-vitro Models for Drug Development

Biocytogen Enters into Antibody Agreement with ADC Therapeutics

GARDP and Mitsubishi Tanabe Pharma Corporation announce partnership in search for new antibiotics

AbbVie Announces European Commission Approval of SKYRIZI (risankizumab) for the Treatment of Moderate to Severe Active Crohn’s Disease

Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect Formulation of Teprotumumab

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation

Sirona Biochem Signs International Partnership Agreement with Wanbang Biopharmaceuticals

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility